Xtandi 80 mg/1
enzalutamide · TABLET · Astellas Pharma US, Inc.
Xtandi (enzalutamide) is a prescription tablet taken by mouth that works by blocking androgen receptors and is used to treat certain types of prostate cancer. It belongs to a class of medications called androgen receptor inhibitors.
Key Facts
- Brand Name
- Xtandi
- Generic Name
- enzalutamide
- NDC Code (Product)
0469-0725- Manufacturer
- Astellas Pharma US, Inc.
- Strength
- 80 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA213674
- Drug Class
- Androgen Receptor Inhibitor [EPC]
- Marketing Start
- 08/04/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Xtandi used for?
Xtandi (enzalutamide) is a prescription tablet taken by mouth that works by blocking androgen receptors and is used to treat certain types of prostate cancer. It belongs to a class of medications called androgen receptor inhibitors.
Is Xtandi a controlled substance?
Xtandi is not classified as a controlled substance by the DEA.
What is the generic name for Xtandi?
The generic name for Xtandi is enzalutamide. There are no other listed brand versions of enzalutamide.
What is the NDC code for Xtandi 80 mg/1?
The NDC (National Drug Code) for Xtandi 80 mg/1 is 0469-0725, listed by Astellas Pharma US, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)